Bayer Group makes air polluter list; Netherlands promises India a halt to generics seizures;

> Bayer Group tops the Toxic 100 Air Polluters list published by the Political Economy Research Institute. Release | List

> The Netherlands has assured India that the incidents of generic drugs seizures in Europe would not recur once the European Commission amends its regulations. Report

> Lorus Therapeutics has completed the cGMP production of the first clinical batch of its anticancer drug candidate LOR-253. Release

> AMPAC Fine Chemicals, a subsidiary of American Pacific Corp., has expanded outside its California base with a multi-purpose manufacturing facility for APIs and intermediates in LaPorte, TX. Announcement

> Consultancy GxPi has been formed by the merger of GxP Consulting and Good Products, providers of consulting services and SharePoint document management solutions. Item

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.